doi: 10.1056/NEJMoa011090
Capsules and powders also remain effective options, allowing for easy dosage control
Oral treatment with -lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial
doi:10.1007/s00244-0 Page 346 and 347: plasma by MALDI-TOF/TOF." Journal o Page 348 and 349: determination of hydrochlorothiazid Page 350 and 351: Ohe T, Watanabe T, and Wakabayashi Page 352 and 353: Onesios K, Yu J, and Bouwer E
During our partners salmon and trout feeding trials, our protein ingredient, Proton, consistently delivered protein digestibility above 94%
The manufacturer (Eli Lilly) has not yet provided an estimated timeline